Skip to main content

What the FDA labels say about taking them together

Ganciclovir and probenecid

Ganciclovir's FDA label of January 9, 2026 names probenecid in its drug interactions section; the probenecid label PlainMeds reads does not name ganciclovir. The ganciclovir label: “Ganciclovir for Injection dose may need to be reduced. Monitor for evidence of ganciclovir toxicity.”

Check it at the source: the ganciclovir FDA label on DailyMed (effective January 9, 2026, Fresenius Kabi USA, LLC); the probenecid FDA label on DailyMed (effective January 5, 2021, Lannett Company, Inc.).

What does the ganciclovir label say about probenecid?

Ganciclovir label, drug interactions

Name of the Concomitant Drug: Probenecid; Change in the Concentration of Ganciclovir or Concomitant Drug: ↑Ganciclovir; Clinical Comment: Ganciclovir for Injection dose may need to be reduced. Monitor for evidence of ganciclovir toxicity.

Source: FDA drug label (Ganciclovir), Fresenius Kabi USA, LLC, effective January 9, 2026 (SPL set 35addab5-09db-4f8a-9c69-6fbce33ecc37), via openFDA; the full label on DailyMed

What does the probenecid label say about ganciclovir?

Probenecid's label (effective January 5, 2021) does not name ganciclovir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Probenecid), Lannett Company, Inc., effective January 5, 2021 (SPL set ab497fd8-00c3-4364-b003-b39d21fbdf38), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

6Ganciclovir generic labelers
6Probenecid generic labelers
GanciclovirProbenecid
Labeled forn/aGout
Boxed warningYesNo
Pharmacy cost (NADAC)$91.24 per gram 0.15% ophthalmic gel$0.636 per tablet 500 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?